HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood
about
Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluidsResistance to HIV InfectionHIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian womenReduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmissionImmunity to HIV-1 is influenced by continued natural exposure to exogenous virus.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimenGenetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.Infection with HIV-1.Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatmentIdentification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.Mucosal correlates of protection in HIV-1-exposed sero-negative persons.Risk and management of blood-borne infections in health care workers.Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals.Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero.Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.Non-human primate models for AIDS vaccine research.Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals.Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.Evidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacyDiscordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV.Low maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses.Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergyHuman immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India.Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected childrenDissecting the HIV-specific immune response: a systems biology approach.HIV Vaccine Strategies - an Update.Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individualsDifferential regulatory T cell activity in HIV type 1-exposed seronegative individuals.Nonhuman primate models of NeuroAIDSImpaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals.Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients.Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships.Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope levelOccupational exposure to human immunodeficiency virus: what healthcare providers should know.Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates.Direct Detection of T- and B-Memory Lymphocytes by ImmunoSpot® Assays Reveals HCMV Exposure that Serum Antibodies Fail to Identify.
P2860
Q24531918-03E36167-A147-4398-9233-DEB1686783E3Q24682788-50A1BD57-CE47-4527-B5D9-F453DEC9E597Q27473466-DA8C2A57-F204-4247-96E1-5FCF8938561AQ28291024-12803527-C0F0-42F4-A1BB-82585B36286CQ28362322-FC9FA23A-64AF-4C8D-89BD-F35F1FCF2406Q33379075-2880EFE3-ECA9-4124-84B1-B23E5D2E1D99Q33611645-C8804620-E3E4-4F1B-949B-F21F4BAD5093Q33649842-2E642E5F-D2BA-4919-9AC0-4103B97A8119Q33784952-4620C222-EEDD-49D3-B1B6-C5001C77DF29Q33792479-B7DB3B5A-D09A-4566-84C5-8E7FC89378A1Q33799700-894BF538-2577-4294-B05E-BE06927CBF84Q33839448-5F87E87F-8A63-4042-BCBD-7CB87DF8898DQ33911540-EB535201-CD3B-4E9C-8E5F-84B9522A4832Q33961883-A435B48B-C3CD-4EE9-A7BD-78D8ECF0E437Q34437201-44815C9C-1EB8-4674-ADC2-863B2C645359Q34461381-2F2D6486-4C80-4176-9938-2D72EA614190Q34620836-E1BB17B8-74D6-40CC-84F2-BE8C07852537Q34715769-612DD45E-87E7-45A7-B8C6-B02DE5440B7BQ34996361-4876CB7C-9D9E-4D01-852D-B3A6CA37227BQ35085106-8C181578-5952-48C5-AE8E-12A7214D5057Q35127088-4DE82E4A-CE92-418A-9AE0-7B7C6522A6C3Q35506920-BFA355AB-71F2-4E93-8C43-46FA6BC6D1F8Q35783507-36CA40F8-CF55-4394-8520-5869C9E894E3Q35895851-394D6A23-958F-4477-B5AE-7B5CB49FD305Q35920663-EF9B8919-29F3-44AC-BC42-755BE6D1C27BQ36095125-83CBFE75-CC23-4DAF-ABFC-0667F051F577Q36625854-28B5ABE1-14C9-446C-988F-2B7506B585C4Q36769115-F75C97E5-140A-47F7-891A-27F3ACA90F5FQ37042991-C1E17983-A30D-4DBA-965C-16E00A3D67BEQ37050078-064287DB-537A-4702-9317-D67C1F281C66Q37204127-8B11451A-4E5A-4841-8D25-2EE80A169784Q37264017-CDA7186F-569A-4B38-9466-B12C0E5DB5BCQ37393689-B0F129B6-516E-4CBE-A3F7-8612493B64B2Q37596619-B65EB544-1FD7-4400-9099-2A5B6EBEBAA7Q37854081-504AB08D-A791-42D9-801A-8ACE6E7BC651Q40248163-0A2A6921-0CD1-415B-B543-D0A950C0EFFEQ41820756-5E24F7B8-46F0-42C2-AEFB-5E8151E7C157Q45114909-BF48CE8A-AB10-450D-AD46-0604821A6E44Q47582681-5ECF944D-2BE5-44EC-8FA9-ABDF4EF440B4Q55408861-02DEEE51-B84C-4599-9CBC-129EDFE8DA8C
P2860
HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
HIV-specific T-helper activity ...... exposed to contaminated blood
@ast
HIV-specific T-helper activity ...... exposed to contaminated blood
@en
HIV-specific T-helper activity ...... exposed to contaminated blood
@nl
type
label
HIV-specific T-helper activity ...... exposed to contaminated blood
@ast
HIV-specific T-helper activity ...... exposed to contaminated blood
@en
HIV-specific T-helper activity ...... exposed to contaminated blood
@nl
prefLabel
HIV-specific T-helper activity ...... exposed to contaminated blood
@ast
HIV-specific T-helper activity ...... exposed to contaminated blood
@en
HIV-specific T-helper activity ...... exposed to contaminated blood
@nl
P2093
P356
P1476
HIV-specific T-helper activity ...... exposed to contaminated blood
@en
P2093
A L Landay
G M Shearer
H A Kessler
J A Berzofsky
P356
10.1001/JAMA.271.1.42
P407
P577
1994-01-05T00:00:00Z